funding

Eye disease therapies being developed after Breye Therapeutics’ €4M seed financing
Labiotech.eu
Thu, 11/10/22 - 10:16 pm
Breye Therapeutics
retinal diseases
funding
NRG Therapeutics Scores $18M to Target Mitochondrial Dysfunction in Parkinson's, ALS
BioSpace
Thu, 11/10/22 - 10:25 am
NRG Therapeutics
funding
Parkinson's Disease
ALS
Biohaven fuels up for post-Pfizer future with $302M fundraising, fresh faces in the C-suite
Fierce Biotech
Wed, 11/9/22 - 10:41 am
Biohaven
Pfizer
funding
epilepsy
Sensorium closes $30M deal to advance drug discovery engine
Labiotech.eu
Wed, 11/9/22 - 10:23 am
Sensorium Therapeutics
SENS-01
drug discovery
funding
Zenas zips up $118M to launch phase 3 for rare autoimmune disease candidate
Fierce Biotech
Tue, 11/8/22 - 10:22 pm
Zenas BioPharma
Xencor
funding
autoimmune disease
Lusaris Launches with $60M to Advance Psychedelic-Based Depression Therapeutic
BioSpace
Thu, 11/3/22 - 11:00 am
Lusaris Therapeutics
funding
LSR-1019
depression
treatment-resistant depression
A Chicago biotech skips the IPO in favor of late-stage Series D for a PhIII Tourette drug
Endpoints
Thu, 11/3/22 - 10:58 am
Emalex Biosciences
funding
Tourette syndrome
J.P. Morgan Launches Life Sciences Fund to Support Early-Stage Biotech
BioSpace
Wed, 11/2/22 - 10:45 pm
JPMorgan
biotech
funding
Concerto Biosciences Raises $23 Million in Series A to Advance Product Development, Expand Pipeline
BioSpace
Wed, 11/2/22 - 10:07 am
Concerto Biosciences
funding
microbiome
Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery
MedCity News
Fri, 10/21/22 - 10:42 am
Surge Therapeutics
Harvard
immunotherapy
solid tumors
funding
Novartis-partnered Orionis secures $55M to push cytokine program into clinic
Endpoints
Wed, 10/19/22 - 10:55 am
Orionis Biosciences
Novartis
funding
R&D
cytokines
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
BioSpace
Wed, 10/19/22 - 10:44 am
Nucleome Therapeutics
funding
precision medicine
autoimmune diseases
Pfizer
JNJ
Merck KGaA
autoimmune disease
Eyenuk raises $26M for diabetic retinopathy screening tech
MedCity News
Tue, 10/18/22 - 10:49 am
Eyenuk
diagnostics
funding
diabetes
diabetic retinopathy
Medtech bleeds corporate venture cash
EP Vantage
Mon, 10/17/22 - 10:24 am
Medtech
venture capital
funding
Odyssey Therapeutics $168 million Series B financing oversubscribed
Pharmaphorum
Fri, 10/14/22 - 10:12 am
Odyssey Therapeutics
oncology
funding
Sea creature-inspired biotech Ascidian surfaces with $50M and a new way to edit RNA
MedCity News
Wed, 10/12/22 - 10:32 am
Ascidian Therapeutics
RNA
Stargardt disease
funding
Brain disease startup Neumora draws more funding for ambitious research plan
BioPharma Dive
Tue, 10/11/22 - 10:22 am
Neumora
neurodegenerative disease
psychiatric disease
funding
Ochre Bio Raises $30M Series A Financing for the Development of RNA Therapies for Chronic Liver Diseases
Yahoo/Businesswire
Mon, 10/10/22 - 10:35 am
Ochre Bio
funding
RNA therapeutics
After selling startups to Novo and Pfizer, Andera raises record €456M for latest life sciences fund
Fierce Biotech
Mon, 10/10/22 - 10:30 am
Andera Partners
funding
life sciences
startups
Pfizer
Novo Nordisk
Europe
venture capital
Versant-founded biotech Nested hatches with $90M and new take on cancer drugs
MedCity News
Fri, 10/7/22 - 10:40 am
Nested Therapeutics
cancer
Versant Ventures
funding

Pages